The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung CancerAdam J. Schoenfeld, Gregory J. Riely, Sonal Paul et al.|Clinical Cancer Research|2020Cited by 281
COVID-19 in patients with lung cancerJie Luo, Matthew D. Hellmann, Hira Rizvi et al.|Annals of Oncology|2020Cited by 269
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Charles M. Rudin, Fathema Uddin et al.|Immunity|2022Cited by 123
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V. Alessi, Mark M. Awad, Arielle Elkrief et al.|Journal of Thoracic Oncology|2023Cited by 91